Spotlight Medical develops AI-driven prognosis tests that utilize extensive patient data to enhance treatment selection for cancer care. The company addresses the challenge of inadequate treatment options by providing personalized insights into each patient's unique disease profile, aiming to improve outcomes and increase the likelihood of remission.
Funding
$6.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Selecting the most effective cancer treatment is challenging due to the limitations of current diagnostic methods in fully capturing the unique characteristics of each patient's disease. This can lead to suboptimal treatment choices and reduced chances of remission.
Solution
Spotlight Medical is developing AI-driven prognosis tests that analyze extensive patient data to provide personalized insights into individual cancer profiles, assisting physicians in selecting the most effective treatment strategies. By leveraging advanced artificial intelligence and a unique technology, the platform aims to improve patient outcomes and increase the likelihood of remission. The tests provide a more comprehensive understanding of the disease, enabling clinicians to make more informed decisions tailored to each patient's specific needs. This approach addresses the critical issue of inadequate cancer treatments by offering a data-driven, personalized approach to treatment selection.
Target Audience
The primary users are physicians and oncologists seeking advanced diagnostic tools to improve cancer treatment selection and patient outcomes.
Features
- AI-driven analysis of extensive patient data to generate personalized cancer profiles.
- Prognosis tests designed to assist physicians in selecting the most effective treatment strategies.
- Technology developed to provide a more comprehensive understanding of the disease.